What is Encoded?
Encoded operates as a specialized Payment Service Provider, focusing on delivering secure and compliant payment solutions tailored for contact centers. Their comprehensive suite of services includes IVR Payments, Agent Assisted Payments, eCommerce Payments, and a sophisticated Fraud Prevention Platform. Designed to meet stringent PCI DSS compliance standards, Encoded's technology empowers leading UK brands to streamline payment processes, thereby enabling them to concentrate on enhancing customer engagement and driving revenue. The company's omnichannel payment solutions and gateway services are engineered for seamless and secure transaction processing across diverse platforms.
How much funding has Encoded raised?
Encoded has raised a total of $239M across 2 funding rounds:
Series C
$104M
Series D
$135M
Series C (2019): $104M with participation from ARCH VENTURE PARTNERS, Venrock, Matrix Capital Management Company, and Illumina Ventures
Series D (2020): $135M led by ARCH Venture Partners, Nolan Capital LLC, RTW Investments , LP, Google Ventures, Illumina Ventures, Boxer Capital , LLC, and Matrix Capital Management Company, L.P.
Key Investors in Encoded
ARCH Venture Partners
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
Google Ventures
GV is a venture capital firm founded in 2001 that invests across multiple stages and sectors. The company focuses on enterprise solutions, life sciences, consumer products, and frontier technology innovations. GV operates globally with presence across North America, Europe, Asia, and South America, providing financial backing to promising startups and growth-stage businesses. The firm maintains a diverse investment portfolio spanning technology, healthcare, and various other industries.
Illumina Ventures
Illumina Ventures is a leader in genomics and precision health investing, focused on building an ecosystem that translates investment into innovation to enhance human health. The company supports various portfolio companies that are advancing life science research, biopharmaceutical drug development, and gene editing technologies. Their intended clients include researchers and organizations in the life sciences and healthcare sectors. Illumina Ventures aims to accelerate impactful solutions in the field of genomics.
What's next for Encoded?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Encoded. This capital injection is anticipated to accelerate the company's market penetration, enhance its technological infrastructure, and potentially expand its service offerings into new verticals or geographies. Strategic partnerships and further product development are likely priorities as Encoded aims to solidify its leadership in the secure payment solutions market, particularly within the contact center industry. The company's trajectory suggests a focus on scaling operations and reinforcing its competitive advantage through continuous innovation and robust security protocols.
See full Encoded company page
